Term
|
Definition
Soluable protein coating; proteins synthesized in the blood, lymph, and extracellular fluids. Coats the surface of bacreria & extracellular viruses to make them more easily phagocytosed. |
|
|
Term
|
Definition
Inactive complement components (often, proteases) |
|
|
Term
|
Definition
Cascade of enzymatic reactions involving proteases, in which each protease cleaves and activates the next enzyme in the pathway |
|
|
Term
|
Definition
Complement component 3.
Most important.
Complement activation leads to the cleavage of C3 into small C3a and a large C3b.
High energy thioester bond within the glycoprotein. |
|
|
Term
|
Definition
Attachment of C3b to a pathogens surface; tags for destruction/organizes the formation of protein complex that can also damage the pathogen |
|
|
Term
|
Definition
Pathway at the start of infection |
|
|
Term
|
Definition
Second pathway.
Induced by infection and requires some time before it gains strength. |
|
|
Term
|
Definition
Innate & Adaptive.
Requires the binding of an antibody or an innate immune-system protein called C-reactive protein to the pathogen's surface |
|
|
Term
|
Definition
Exposure and hydrolysis of the thioester bond of a small proportion of C3 molecules.
No cleavage of C3.
Catalyzed by certian pathogens in the environment (particularly bacteria) |
|
|
Term
|
Definition
Inactive complement of iC3.
Susceptivle to cleavage by protease. |
|
|
Term
|
Definition
Protease that cleaves Factor B |
|
|
Term
|
Definition
Proteases taht cleave an activate C3.
i.e. iC3Bb |
|
|
Term
|
Definition
Small fragment that is realeased from the cleavage of Factor B. |
|
|
Term
|
Definition
Fragment that is released from the cleavage of Factor B. has protease activity.
Remains bound to iC3
Alternative pathway |
|
|
Term
|
Definition
Cleaves (by protease activity) intact C3 molecules into C3a and C3b fragments. |
|
|
Term
|
Definition
Potent C3 convertase.
Alternative C3 convertase.
Works at the surface of the pathogen.
Binds C3 and cleaves into C3b & Bb with activation of the thioester bond. |
|
|
Term
Intital deposition of a few molecules of C3b... |
|
Definition
Starts a positive feedback system; rapidly coats the pathogen |
|
|
Term
Complement control proteins |
|
Definition
Plasma proteins.
Memberane proteins. |
|
|
Term
|
Definition
Properdin.
Increases the speed and power of complement activation by binding the C3 convertase C3bBb on microbial surfaces and preventing its degradation by proteases. |
|
|
Term
|
Definition
Plasma protein.
Binds to C3b and facilitates furthur cleavage to form iC3b by plasma serine protease, Factor I. |
|
|
Term
|
Definition
Plasma serine protease
The combined factors H & I reduces the number of C3 convertase molceules on the pathogens surface |
|
|
Term
|
Definition
Decay-accelerating factor.
Binds to the C3b component of the alternative C3 convertase (C3bBb), causing dissociation and inactivation.
In human cells. |
|
|
Term
|
Definition
Membrane co-factor protein.
MCP and C3b makes it also possible susceptible to cleavage by inactivation by Factor I. |
|
|
Term
|
Definition
Complement control protein modules.
Elongated structures built from varying numbers of structurally similar modules.
i.e. DAF, MCP, and Factor H |
|
|
Term
|
Definition
Regulators of complement activation.
Proteins made up of CCP modules. |
|
|
Term
|
Definition
Mature forms of circulating monocytes that have left the blood and taken up residence in tissues. |
|
|
Term
|
Definition
Macrophages that reside in the liver |
|
|
Term
|
Definition
Complement receptor 1.
A receptor that binds C3b fragments that have been deposited at high density on the surface of a pathogen through activation of the alternative pathway of complement. |
|
|
Term
|
Definition
The coating of a pathogen with a protein that facilitates phagocytosis. |
|
|
Term
|
Definition
Complement receptor 3 & 4.
Bind to iC3b fragments on microbial surfaces. |
|
|
Term
|
Definition
Alernative C5 convertase.
Consits of Bb plus two fragments.
C3b binds to the alternative C3 convertase to produce an enzyme that acts on the C5 component of complement. |
|
|
Term
|
Definition
Can make holes in the membranes of bacterial pathogens and eukaryotic cells. |
|
|
Term
|
Definition
Homologous restriction factor |
|
|
Term
|
Definition
Protectin.
w/ HRF prevent the recruitment of C9 by the complex of C5b, C6, C7, and C8. |
|
|
Term
Paroxysmal nocturnal hemoglobunuria |
|
Definition
DAF, HRF, and CD59 are all linked to the plasma membrane by glycosylphatidylinositol lipid tails.
Impaired synthesis of this tail.
Disease: episodes of complement mediated lysis of red blood cells that lack cell surface DAF, HRF, and CD59. |
|
|
Term
|
Definition
The C3a and C5a fragments that induce anaphylactic shock |
|
|
Term
|
Definition
Plasma enzymes that form blood clots.
Immobilize microorganisms and prevent them from entering the blood and lymph.
Reduces the loss of blood a fluid. |
|
|
Term
|
Definition
Secondary enzymatic cascade of plasma proteins triggered by tissue damage. |
|
|
Term
|
Definition
Antimicrobial peptides made up of 35-40 amino acids that are rich in positivelt charged argnine residues and which characteristically have three intra-chain disulfide bonds.
|
|
|
Term
|
Definition
The receptors and plasma proteins taht recognize carbohydrates |
|
|
Term
|
Definition
A phagocytic receptor of macrophages that is not a lictin; it binds to an assortment of ligands that share the property of being negatively charged |
|
|
Term
|
Definition
Recruit other immune system cells into the infected tissues, where they work together with macrophages |
|
|
Term
|
Definition
Toll-like receptors.
A family of signaling receptors, each which is specific for a different set of microbial products |
|
|
Term
|
Definition
Specifity for the bacterial lipopolysaccharide (LPS) and related compounds present on the outside of G(-) bacteria.
Sends signals to the macrophage when infection is present to change the pattern of gene expression. |
|
|
Term
|
Definition
Genes for cytokines that induce innate immune responses and inflammation at the site of infection |
|
|
Term
|
Definition
Leucine-rich repeat region |
|
|
Term
|
Definition
Proteins.
Acts as a co-receptor to TLR4.
CD14 and MD2 form a complex with the LPS; the complex generates intracellular signals via the cytoplasmic signaling domain of TLR4 |
|
|
Term
|
Definition
Nuclear factor kB
Transcription factor which plays a major role in innate & adaptive immune responses |
|
|
Term
|
Definition
|
|
Term
|
Definition
X-linked hypohydrotic ectodermal dysplasia and immunodeficiency
Disease: children lack one of the subunits of IKK and thus have impaired activation of NFkB; makes children susceptible to bacterial infection |
|
|
Term
|
Definition
Natural killer lymphocytes.
Enter infected sites soon after infection.
Specalize in defense against viral infections. |
|
|
Term
|
Definition
Molecules involved in the induction of inflammation |
|
|
Term
|
Definition
The arrival of neutrophils is the first of a series of reactions; cells and molecules of innate immunity are recruited into sites of wounding or infection |
|
|
Term
Prominent cytokines produced by activated macrophages |
|
Definition
IL-1, IL-6, CXCL8, IL-12, and tumor necrosis factor-a (alpha) (TNF-a)
:These can be localized or systemic |
|
|
Term
|
Definition
Chemoattractant cytokines (chemokines); direct the flow of leukocytes during their development and during their recirculation through lymphoid tissues
Primary function: recruit neutrophils from the blood into infected areas |
|
|
Term
|
Definition
Chemokine receptors which will bind CXCL8 from an infected tissue |
|
|
Term
|
Definition
Activates NK cells (lymphocyte) |
|
|
Term
|
Definition
Causes vascular endothelial cells to make platelet-activating factor -- triggers blood clotting and blockage of the local blood vessels |
|
|
Term
|
Definition
Disseminated intravascular coagulation
Exhausts the supply of clotting proteins |
|
|
Term
|
Definition
Pus-forming
i.e. S. aureus |
|
|
Term
|
Definition
Carbohydrate-binding proteins, lectins, which have specificity for the oligosaccharides of different vascular addressins |
|
|
Term
|
Definition
A large family of adhesion molecules with a common structure of a-chain and B-chain polypeptides
i.e. C3 & C4 |
|
|
Term
|
Definition
Carbohydrate rich in sialic acid and is one of the antigens in the Lewis blood group system |
|
|
Term
|
Definition
The process of a leukocyte moving between two endothelial cells |
|
|
Term
|
Definition
In a neutrophil.
Packed with proteins and peptides that can disrupt and digest microbes.
i.e. proteases |
|
|
Term
|
Definition
Contain unsaturated lactoferrin; which competes with pathogens for iron and copper by binding to proteins that contain these materials
Also contain: lysozyme and membrane proteins such as NADPH oxidase |
|
|
Term
|
Definition
Produces superoxide radicals that are converted into hydrogen peroxide by the enzyme superoxide dismutase
Raises the pH of the phagosome within 3 minutes of phagocytosis to ~8 |
|
|
Term
|
Definition
Active at the lower pH of the phagolysosome & ensure continued use and complete breakdown of the pathogens macromolecules |
|
|
Term
|
Definition
Molecules that induce fever |
|
|
Term
|
Definition
Mannose-binding lectin.
A calcium-dependent lectin that binds to mannose-containing carbohydrates of bacteria, fungi, protozoans, and viruses.
Member of the protein family: collectins (collegen + lechtin properties) |
|
|
Term
|
Definition
C-reactive protein.
Member of the pentraxin family of proteins: contains 5 identical subunits that from a pentamer
Binds to the phosphocholine component of LPS in bacterial and fungal cell walls
Founded by binding to : Streptococcus pneumoniae |
|
|
Term
|
Definition
MBL- associated serine proteases.
Asssociate with the main stalk of the mannose-binding lectin
MASP-2 has an enzymatic role in lectin-mediated complement activation. |
|
|
Term
|
Definition
Anaphylatoxin that can recruit leukocytes to the site of C4b fixiation
Involved in the lectin and classical pathways |
|
|
Term
|
Definition
C3 convertase
This convertase is where the lectin and classical pathways converge. |
|
|
Term
|
Definition
Inactive serine proteases. |
|
|
Term
|
Definition
Cytokines that are produced when an infection enters a cell.
Interferons interfere with viral replication by the infected cell and to signal neighboring uninfected cells that they too should prepare to resist infection |
|
|
Term
|
Definition
When intracellular receptors Jak1 & Tyk2 kinases initiate rxns that change the expression of a variety of human genes |
|
|
Term
|
Definition
Protein kinase R
Which phosphorylates and inhibits the protein synthesis initiation factor eIF2, preventing viral protein synthesis and the production of new infectious virons. |
|
|
Term
|
Definition
Interferon response factor 7.
Initiates the transcription of IFN-a which does not require the participation of NFkB and AP-1 |
|
|
Term
|
Definition
(Natural) Interferon-producing cells.
These cells can produce up to 1000 times more interferon than other cells. |
|
|
Term
Plasmacytoid dendritic cell |
|
Definition
Congregate in the T-cell areas of draining lymph nodes; can produce interferon |
|
|
Term
Conventional dendritic cells
Innnate |
|
Definition
Make relatively small amounts of type I interferons but produce large amounts of IL-12 |
|
|
Term
|
Definition
Type II interferon
Activates macrophages-- initiates adaptive immune response |
|
|
Term
|
Definition
An activating lectin-like NK-cell receptor that binds to ligands called MIC-A and MIC-B |
|
|
Term
|
Definition
Cell surface proteins that are produced in response to stress
Produced in intestinal epithelium |
|
|